The Role and Potential of (18)F-FDG PET/CT in Malignant Melanoma: Prognostication, Monitoring Response to Targeted and Immunotherapy, and Radiomics

Novel therapeutic approaches, consisting of immune check-point inhibitors (ICIs) and molecularly targeted therapy, have thoroughly changed the clinical management of malignant melanoma (MM), the most frequent and deadly skin cancer. Since only 30–40% of MM patients respond to ICIs, imaging biomarker...

Descripción completa

Detalles Bibliográficos
Autores principales: Filippi, Luca, Bianconi, Francesco, Schillaci, Orazio, Spanu, Angela, Palumbo, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028862/
https://www.ncbi.nlm.nih.gov/pubmed/35453977
http://dx.doi.org/10.3390/diagnostics12040929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9028862/
https://www.ncbi.nlm.nih.gov/pubmed/35453977
http://dx.doi.org/10.3390/diagnostics12040929

Ejemplares similares